1293 related articles for article (PubMed ID: 22208383)
21. Gateways and tools for drug delivery: endocytic pathways and the cellular dynamics of cell penetrating peptides.
Jones AT
Int J Pharm; 2008 Apr; 354(1-2):34-8. PubMed ID: 18068916
[TBL] [Abstract][Full Text] [Related]
22. Insights into the cellular trafficking of splice redirecting oligonucleotides complexed with chemically modified cell-penetrating peptides.
Hassane FS; Abes R; El Andaloussi S; Lehto T; Sillard R; Langel U; Lebleu B
J Control Release; 2011 Jul; 153(2):163-72. PubMed ID: 21536086
[TBL] [Abstract][Full Text] [Related]
23. Cell-penetrating peptide-based systems for nucleic acid delivery: a biological and biophysical approach.
Trabulo S; Cardoso AL; Cardoso AM; Düzgüneş N; Jurado AS; de Lima MC
Methods Enzymol; 2012; 509():277-300. PubMed ID: 22568911
[TBL] [Abstract][Full Text] [Related]
24. siRNA and pharmacological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating peptides octaarginine (R8) and HIV-Tat.
Al Soraj M; He L; Peynshaert K; Cousaert J; Vercauteren D; Braeckmans K; De Smedt SC; Jones AT
J Control Release; 2012 Jul; 161(1):132-41. PubMed ID: 22465675
[TBL] [Abstract][Full Text] [Related]
25. Cell Penetrating Peptide Conjugated Chitosan for Enhanced Delivery of Nucleic Acid.
Layek B; Lipp L; Singh J
Int J Mol Sci; 2015 Dec; 16(12):28912-30. PubMed ID: 26690119
[TBL] [Abstract][Full Text] [Related]
26. Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells.
Nakase I; Tanaka G; Futaki S
Mol Biosyst; 2013 May; 9(5):855-61. PubMed ID: 23306408
[TBL] [Abstract][Full Text] [Related]
27. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
[TBL] [Abstract][Full Text] [Related]
28. Unraveling the Mechanisms of Peptide-Mediated Delivery of Nucleic Acids Using Electron Microscopy.
Margus H; Juks C; Pooga M
Methods Mol Biol; 2015; 1324():149-62. PubMed ID: 26202268
[TBL] [Abstract][Full Text] [Related]
29. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
[TBL] [Abstract][Full Text] [Related]
30. Recent advances in the use of cell-penetrating peptides for medical and biological applications.
Fonseca SB; Pereira MP; Kelley SO
Adv Drug Deliv Rev; 2009 Sep; 61(11):953-64. PubMed ID: 19538995
[TBL] [Abstract][Full Text] [Related]
31. PepFects and NickFects for the Intracellular Delivery of Nucleic Acids.
Arukuusk P; Pärnaste L; Hällbrink M; Langel Ü
Methods Mol Biol; 2015; 1324():303-15. PubMed ID: 26202277
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of Cell-Penetrating Peptide/Nucleic Acid Nanoparticles.
Margus H; Arukuusk P; Langel Ü; Pooga M
Mol Pharm; 2016 Jan; 13(1):172-9. PubMed ID: 26561739
[TBL] [Abstract][Full Text] [Related]
33. Membrane Crossing and Membranotropic Activity of Cell-Penetrating Peptides: Dangerous Liaisons?
Walrant A; Cardon S; Burlina F; Sagan S
Acc Chem Res; 2017 Dec; 50(12):2968-2975. PubMed ID: 29172443
[TBL] [Abstract][Full Text] [Related]
34. Thermodynamics of lipid interactions with cell-penetrating peptides.
Sauder R; Seelig J; Ziegler A
Methods Mol Biol; 2011; 683():129-55. PubMed ID: 21053127
[TBL] [Abstract][Full Text] [Related]
35. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
Crombez L; Morris MC; Heitz F; Divita G
Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
[TBL] [Abstract][Full Text] [Related]
36. A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway.
Mudhakir D; Akita H; Tan E; Harashima H
J Control Release; 2008 Jan; 125(2):164-73. PubMed ID: 18054812
[TBL] [Abstract][Full Text] [Related]
37. Application of PepFect peptides for the delivery of splice-correcting oligonucleotides.
Andaloussi SE; Lehto T; Lundin P; Langel U
Methods Mol Biol; 2011; 683():361-73. PubMed ID: 21053143
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of transportan 10 in PEI mediated plasmid delivery assay.
Kilk K; El-Andaloussi S; Järver P; Meikas A; Valkna A; Bartfai T; Kogerman P; Metsis M; Langel U
J Control Release; 2005 Mar; 103(2):511-23. PubMed ID: 15763630
[TBL] [Abstract][Full Text] [Related]
39. Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides.
Fischer R; Fotin-Mleczek M; Hufnagel H; Brock R
Chembiochem; 2005 Dec; 6(12):2126-42. PubMed ID: 16254940
[TBL] [Abstract][Full Text] [Related]
40. Effects of tryptophan content and backbone spacing on the uptake efficiency of cell-penetrating peptides.
Rydberg HA; Matson M; Amand HL; Esbjörner EK; Nordén B
Biochemistry; 2012 Jul; 51(27):5531-9. PubMed ID: 22712882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
